Home › Companies › STOKE THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and STOKE THERAPEUTICS INC.’s Form 8-K, filed June 4, 2025 (Item 5.07 on EDGAR). Page generated November 7, 2026.
Meeting of June 3, 2025: 5 items on STOKE THERAPEUTICS INC.’s Form 8-K, filed June 4, 2025: 5 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore STOKE THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are STOKE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Edward M. Kaye, M.D. | 29,220,313 | -- | -- | 4,224,823 | 5,350,616 | 87% | Not verified | — |
| Elect Director: Seth L. Harrison, M.D. | 29,269,703 | -- | -- | 4,175,433 | 5,350,616 | 88% | Not verified | — |
| Elect Director: Arthur O. Tzianabos, Ph.D. | 29,241,848 | -- | -- | 4,203,288 | 5,350,616 | 87% | Not verified | — |
| 2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 38,678,091 | 67,754 | 49,907 | -- | -- | 99.8% | Not verified | — |
| 3. Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers as disclosed in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 22, 2025 | 30,543,514 | 2,882,907 | 18,715 | -- | 5,350,616 | 91% | Not verified | — |
Source: STOKE THERAPEUTICS INC., Form 8-K, filed with the SEC on June 4, 2025 — read the filing on EDGAR.
Each item below shows how the 135 asset managers that disclosed a STOKE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of STOKE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors to serve until the 2028 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Arthur O. Tzianabos, Ph.D.
STOKE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Arthur O. Tzianabos, Ph.D.”): 29,241,848 for, 4,203,288 withheld, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 46 asset managers below reported 4,583,764 for, 2,404,994 withheld, 133,556 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,713,712 | 0 | 0 | 0 | For |
| Fidelity | 430,976 | 0 | 0 | 1,846,841 | Mixed |
| BlackRock | 864,469 | 0 | 0 | 0 | For |
| Charles Schwab | 310,229 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 230,089 | Withhold |
| Jackson National | 0 | 0 | 116,210 | 0 | Abstain |
| Equitable | 65,639 | 0 | 0 | 40,630 | Mixed |
| TIAA | 81,434 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 78,813 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 51,781 | Withhold |
| State Street | 92 | 0 | 0 | 38,795 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 26,368 | 0 | 0 | 0 | For |
| Northern Trust | 26,257 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 21,838 | Withhold |
| Global X | 21,138 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 18,423 | Withhold |
| Brighthouse | 0 | 0 | 0 | 11,723 | Withhold |
| PFM Multi-Manager Series Trust | 0 | 0 | 11,200 | 0 | Abstain |
| Pacific Life | 10,686 | 0 | 0 | 0 | For |
| Nationwide | 10,558 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 10,414 | Withhold |
| Voya | 0 | 0 | 0 | 9,864 | Withhold |
| ETFis Series Trust I | 0 | 0 | 0 | 8,290 | Withhold |
| Prudential/PGIM | 0 | 0 | 0 | 7,930 | Withhold |
| Bridge Builder Trust | 6,905 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.
Combines 3 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors to serve until the 2028 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Edward M. Kaye, M.D.
STOKE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Edward M. Kaye, M.D.”): 29,220,313 for, 4,224,823 withheld, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 46 asset managers below reported 4,512,387 for, 2,476,371 withheld, 133,556 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,713,712 | 0 | 0 | 0 | For |
| Fidelity | 430,976 | 0 | 0 | 1,846,841 | Mixed |
| BlackRock | 864,469 | 0 | 0 | 0 | For |
| Charles Schwab | 310,229 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 230,089 | Withhold |
| Jackson National | 0 | 0 | 116,210 | 0 | Abstain |
| Equitable | 65,639 | 0 | 0 | 40,630 | Mixed |
| TIAA | 0 | 0 | 0 | 81,434 | Withhold |
| Victory Capital | 0 | 0 | 0 | 78,813 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 51,781 | Withhold |
| State Street | 92 | 0 | 0 | 38,795 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 26,368 | 0 | 0 | 0 | For |
| Northern Trust | 26,257 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 21,838 | Withhold |
| Global X | 21,138 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 18,423 | Withhold |
| Brighthouse | 0 | 0 | 0 | 11,723 | Withhold |
| PFM Multi-Manager Series Trust | 0 | 0 | 11,200 | 0 | Abstain |
| Pacific Life | 10,686 | 0 | 0 | 0 | For |
| Nationwide | 10,558 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 10,414 | Withhold |
| Voya | 9,864 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 8,290 | Withhold |
| Prudential/PGIM | 0 | 0 | 0 | 7,930 | Withhold |
| Bridge Builder Trust | 6,905 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.
Combines 3 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors to serve until the 2028 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Seth L. Harrison, M.D.
STOKE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Seth L. Harrison, M.D.”): 29,269,703 for, 4,175,433 withheld, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 46 asset managers below reported 4,553,066 for, 2,435,692 withheld, 133,556 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,713,712 | 0 | 0 | 0 | For |
| Fidelity | 430,976 | 0 | 0 | 1,846,841 | Mixed |
| BlackRock | 864,469 | 0 | 0 | 0 | For |
| Charles Schwab | 310,229 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 230,089 | Withhold |
| Jackson National | 0 | 0 | 116,210 | 0 | Abstain |
| Equitable | 65,639 | 0 | 0 | 40,630 | Mixed |
| TIAA | 0 | 0 | 0 | 81,434 | Withhold |
| Victory Capital | 0 | 0 | 0 | 78,813 | Withhold |
| Lincoln Financial | 26,400 | 0 | 0 | 25,381 | Mixed |
| State Street | 38,843 | 0 | 0 | 44 | For |
| QUANTITATIVE MASTER SERIES LLC | 26,368 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 26,257 | Withhold |
| ProShares | 0 | 0 | 0 | 21,838 | Withhold |
| Global X | 21,138 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 18,423 | Withhold |
| Brighthouse | 0 | 0 | 0 | 11,723 | Withhold |
| PFM Multi-Manager Series Trust | 0 | 0 | 11,200 | 0 | Abstain |
| Pacific Life | 10,686 | 0 | 0 | 0 | For |
| Nationwide | 10,558 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 10,414 | Withhold |
| Voya | 9,864 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 8,290 | Withhold |
| Prudential/PGIM | 0 | 0 | 0 | 7,930 | Withhold |
| Bridge Builder Trust | 6,905 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.
Combines 6 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
STOKE THERAPEUTICS INC.’s own tally for this item (“3. Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers as disclosed in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission ”): 30,543,514 for, 2,882,907 against, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,713,712 | 0 | 0 | 0 | For |
| Fidelity | 430,976 | 1,846,841 | 0 | 0 | Mixed |
| BlackRock | 864,469 | 0 | 0 | 0 | For |
| Charles Schwab | 310,229 | 0 | 0 | 0 | For |
| Dimensional | 230,089 | 0 | 0 | 0 | For |
| Jackson National | 116,210 | 0 | 0 | 0 | For |
| Equitable | 106,269 | 0 | 0 | 0 | For |
| TIAA | 81,434 | 0 | 0 | 0 | For |
| Victory Capital | 78,813 | 0 | 0 | 0 | For |
| Lincoln Financial | 51,781 | 0 | 0 | 0 | For |
| State Street | 38,887 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 0 | 0 | 0 | 26,737 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 26,368 | 0 | 0 | 0 | For |
| Northern Trust | 26,257 | 0 | 0 | 0 | For |
| ProShares | 21,838 | 0 | 0 | 0 | For |
| Global X | 21,138 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 18,423 | 0 | 0 | 0 | For |
| Brighthouse | 11,723 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 11,200 | 0 | 0 | 0 | For |
| Pacific Life | 10,686 | 0 | 0 | 0 | For |
| Nationwide | 10,558 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 10,414 | 0 | 0 | 0 | For |
| Voya | 9,864 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 8,290 | 0 | 0 | 0 | For |
| Prudential/PGIM | 7,930 | 0 | 0 | 0 | For |
Fund voting reports, all 46 managers: 5,264,767 for, 1,857,547 against, 26,737 withheld. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 4,971,887 | 0 | 0 | 0 | For |
| Lynx1 Capital Management LP | 4,603,233 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 4,444,281 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 1,999,155 | 0 | 0 | 0 | For |
| Fidelity | 0 | 1,948,727 | 0 | 0 | Against |
| Siren, L.L.C. | 1,932,396 | 0 | 0 | 0 | For |
| BlackRock | 1,273,161 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 516,186 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 515,702 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 479,998 | 0 | 0 | 0 | For |
| Granahan Investment Management, LLC | 461,720 | 0 | 0 | 0 | For |
| State Street | 447,294 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 325,306 | 0 | 0 | 0 | For |
| Charles Schwab | 310,229 | 0 | 0 | 0 | For |
| Opaleye Management Inc. | 300,000 | 0 | 0 | 0 | For |
| Cormorant Asset Management, LP | 254,161 | 0 | 0 | 0 | For |
| Birchview Capital, LP | 210,004 | 0 | 0 | 0 | For |
| Northern Trust | 165,825 | 0 | 0 | 0 | For |
| Citadel | 118,746 | 0 | 0 | 0 | For |
| Wellington | 98,852 | 0 | 0 | 0 | For |
| Vanguard | 94,087 | 0 | 0 | 0 | For |
| Woodline Partners LP | 91,881 | 0 | 0 | 0 | For |
| Nuveen | 87,487 | 0 | 0 | 0 | For |
| Dimensional | 86,294 | 0 | 0 | 0 | For |
| UBS | 0 | 56,448 | 0 | 0 | Against |
Institutional-manager reports, all 101 managers: 24,232,566 for, 2,054,939 against, 13,195 1 year. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.4% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF FUTURE STOCKHOLDER ADVISORY VOTES TO APPROVE THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 22,314 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 0 | 0 | 0 | 0 | -- |
| PFM Multi-Manager Series Trust | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| ETFis Series Trust I | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 45 managers: 22,314 for, 6,847,734 1 year, 252,266 3 year. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 0 | 0 | 0 | 0 | -- |
| Lynx1 Capital Management LP | 0 | 0 | 0 | 0 | -- |
| Redmile Group, LLC | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Siren, L.L.C. | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| MPM BioImpact LLC | 0 | 0 | 0 | 0 | -- |
| DAFNA Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Cormorant Asset Management, LP | 0 | 0 | 0 | 0 | -- |
| Birchview Capital, LP | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Woodline Partners LP | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| UBS | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 95 managers: 15,152 for, 216 against, 25,407,704 1 year, 86,294 3 year. Showing the 25 largest; see all in the interactive database.
99.8% Majority: yes · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
STOKE THERAPEUTICS INC.’s own tally for this item (“2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 38,678,091 for, 67,754 against, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 46 asset managers below reported 7,122,314 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,713,712 | 0 | 0 | 0 | For |
| Fidelity | 2,277,817 | 0 | 0 | 0 | For |
| BlackRock | 864,469 | 0 | 0 | 0 | For |
| Charles Schwab | 310,229 | 0 | 0 | 0 | For |
| Dimensional | 230,089 | 0 | 0 | 0 | For |
| Jackson National | 116,210 | 0 | 0 | 0 | For |
| Equitable | 106,269 | 0 | 0 | 0 | For |
| TIAA | 81,434 | 0 | 0 | 0 | For |
| Victory Capital | 78,813 | 0 | 0 | 0 | For |
| Lincoln Financial | 51,781 | 0 | 0 | 0 | For |
| State Street | 38,887 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 26,368 | 0 | 0 | 0 | For |
| Northern Trust | 26,257 | 0 | 0 | 0 | For |
| ProShares | 21,838 | 0 | 0 | 0 | For |
| Global X | 21,138 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 18,423 | 0 | 0 | 0 | For |
| Brighthouse | 11,723 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 11,200 | 0 | 0 | 0 | For |
| Pacific Life | 10,686 | 0 | 0 | 0 | For |
| Nationwide | 10,558 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 10,414 | 0 | 0 | 0 | For |
| Voya | 9,864 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 8,290 | 0 | 0 | 0 | For |
| Prudential/PGIM | 7,930 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,905 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 54,595,714 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.97% |
| 2 | Fidelity | 4.17% |
| 3 | BlackRock | 1.58% |
| 4 | Charles Schwab | 0.57% |
| 5 | Dimensional | 0.42% |
| 6 | Jackson National | 0.21% |
| 7 | Equitable | 0.19% |
| 8 | TIAA | 0.15% |
| 9 | Victory Capital | 0.14% |
| 10 | Lincoln Financial | 0.09% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | RTW INVESTMENTS, LP | 9.11% |
| 2 | Lynx1 Capital Management LP | 8.43% |
| 3 | Redmile Group, LLC | 8.14% |
| 4 | MARSHALL WACE, LLP | 3.66% |
| 5 | Fidelity | 3.57% |
| 6 | Siren, L.L.C. | 3.54% |
| 7 | BlackRock | 2.33% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 0.95% |
| 9 | MPM BioImpact LLC | 0.94% |
| 10 | DAFNA Capital Management LLC | 0.88% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Skorpios Trust | 12.65% | DEF14A |
| RTW Investments, LP | 10.88% | 13G |
| BlackRock | 10.74% | 13F |
| Entities affiliated with RTW Investments, L.P. | 9.73% | DEF14A |
| Lynx1 Capital Management LP | 9.50% | DEF14A |
| Baker Bros. Advisors LP | 8.00% | DEF14A |
| Redmile Group, LLC | 7.63% | 13G |
| Cowen Financial Products LLC | 6.82% | DEF14A |
| Morgan Stanley | 6.28% | 13G |
| The Toronto-Dominion Bank | 5.81% | 13G |
Percentages above are of 54,595,714 shares outstanding, as reported by STOKE THERAPEUTICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from STOKE THERAPEUTICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 7, 2026; a live search always shows the current data.
At STOKE THERAPEUTICS INC.'s shareholder meeting held June 3, 2025, in the 2024-2025 proxy season, 135 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,172 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. — FOR was 91% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: STOKE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2025.
STOKE THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.